Earlier diagnostics enables faster Alzheimer's treatment

Erik L. Ridley
Jun 1, 2023
2023 06 01 22 53 4403 2023 06 02 Quest Video 400

New advances in diagnostics can help detect Alzheimer's disease sooner, enabling patients to benefit from new treatments to slow down progression, said Quest Diagnostics Medical Director for Neurology Dr. Michael Racke in a video interview.


Latest in Molecular Imaging
Pluvicto Spect Ct Response Thumbnail
SPECT/CT predicts treatment response in Pluvicto patients
November 1, 2024
Hyperparathyroidism
FCH-PET emerging in patients with hyperparathyroidism
October 31, 2024
New! Imaging Life Issue 20 now available
Sponsored
New! Imaging Life Issue 20 now available
November 5, 2024
2024 10 28 Meningioma Thumbnail
Intraarterial PRRT safe in patients with meningioma
October 28, 2024
Related Stories
2023 06 25 00 42 9458 2023 06 25 Snmmi Pet Brain Tracer 20230625005536
Nuclear Medicine
PET tracer images brain cholesterol metabolism
2022 01 12 18 18 1479 Patient Elderly Confused Headache 400
Molecular Imaging
CMS to cover Alzheimer's drugs for patients enrolled in registry
2021 10 27 18 08 3227 Business Costs Rising Arrow Up 400
Molecular Imaging
Will lecanemab approval increase PET scan volumes?
New! Imaging Life Issue 20 now available
Sponsor Content
New! Imaging Life Issue 20 now available
More in Molecular Imaging
SPECT/CT predicts treatment response in Pluvicto patients
By Will Morton
SPECT/CT scans taken just four hours after patients begin Lu-177 PSMA-617 treatment can help assess treatment responses.
November 1, 2024
Pluvicto Spect Ct Response Thumbnail
FCH-PET emerging in patients with hyperparathyroidism
By Will Morton
F-18 fluorocholine (FCH) PET/CT appears to be an effective first-line imaging method in patients with primary hyperparathyroidism.
October 31, 2024
Hyperparathyroidism
Ask cardiac PET patients how much they exercise, study suggests
By Will Morton
Exercise activity is an independent predictor of events such as heart attacks in patients undergoing stress PET myocardial perfusion imaging.
October 30, 2024
Heart Attack
Intraarterial PRRT safe in patients with meningioma
By Will Morton
Intraarterial peptide receptor radionuclide therapy (PRRT) is a safe and effective alternative to intravenous PRRT in patients with advanced meningioma.
October 28, 2024
2024 10 28 Meningioma Thumbnail
PSMA-PET provides long-term benefits
By Will Morton
Prostate-specific membrane antigen (PSMA) PET imaging could improve the length and quality of life for patients with recurrent prostate cancer.
October 24, 2024
Prostate Imaging2
New PET tracer improves detection of insulinomas
By Will Morton
A new PET/CT radiotracer that detects insulinomas could eliminate the need for other diagnostic procedures in a vast majority of patients.
October 21, 2024
Glp 1 R Pet 67169a712e569 Thumbnail
Tc-99m shortage expected into November
By Will Morton
The delayed restart of a nuclear research reactor in the Netherlands is expected to cause supply shortages of technetium-99m (Tc-99m) into November.
October 18, 2024
Isotopes
FAPI-PET shows value in staging lung cancer patients
By Will Morton
Fibroblast activation protein inhibitor (FAPI) PET/CT shows excellent diagnostic accuracy for detecting lymph node metastases in lung cancer patients
October 17, 2024
Lung Cancer
New guidelines cover theranostics for brain tumors
By Will Morton
The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise.
October 14, 2024
Brain
NNSA's Mo-99 program: A bumpy ride
By Will Morton
Last year was a bumpy ride for a U.S. initiative to secure domestic supplies of molybdenum-99 (Mo-99).
October 10, 2024
Mo 99
FES-PET improves management of breast cancer patients
By Will Morton
PET/CT imaging with F-18 fluroestradiol (FES) can play a significant role in helping clinicians make treatment decisions in patients with recurrent or metastatic breast cancer
October 7, 2024
2024 10 07 Fes Pet Thumbnail
What impact will flurpiridaz F-18 have on heart care?
By Will Morton
Seventeen years was all it took for flurpiridaz F-18 to reach the market, with the first patient injected with the PET imaging agent in November, 2007.
October 4, 2024
Maddahi
Page 1 of 598
Next Page